Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.60 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.60 |
| ▸ | FAAH | O00519 | 1/20 | 0.57 |
| ▸ | CETP | P11597 | 5/20 | 0.51 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.48 |
| ▸ | TRPM8 | Q7Z2W7 | 4/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL652194 | 1.00 | LPAR3 (0.60) | LPAR3LPAR2FAAHCETPLPAR1 | |
| SCHEMBL653716 | 1.00 | LPAR3 (0.60) | LPAR3LPAR2FAAHCETPLPAR1 | |
| SCHEMBL654332 | 1.00 | LPAR3 (0.60) | LPAR3LPAR2FAAHCETPLPAR1 | |
| SCHEMBL9078658 | 1.00 | LPAR3 (0.60) | LPAR3LPAR2FAAHCETPLPAR1 | |
| SCHEMBL20553273 | 1.00 | LPAR3 (0.60) | LPAR3LPAR2FAAHCETPLPAR1 | |
| SCHEMBL654670 | 1.00 | LPAR3 (0.60) | LPAR3LPAR2FAAHCETPLPAR1 | |
| SCHEMBL9080697 | 1.00 | LPAR3 (0.60) | LPAR3LPAR2FAAHCETPLPAR1 | |
| SCHEMBL14883684 | 1.00 | LPAR3 (0.60) | LPAR3LPAR2FAAHCETPLPAR1 | |
| SCHEMBL655424 | 1.00 | LPAR3 (0.60) | LPAR3LPAR2FAAHCETPLPAR1 | |
| SCHEMBL28965549 | 1.00 | LPAR3 (0.60) | LPAR3LPAR2FAAHCETPLPAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11617707-B2 | Nail varnish composition containing embossed effect pigments and surface-modified embossed effect pigments | ECKART GMBH (DE) | 2023-04-04 | — | — | US | claimed |
| US-20200246232-A1 | Nail Varnish Composition Containing Embossed Effect Pigments and Surface-Modified Embossed Effect Pigments | ECKART GMBH (DE) | 2020-08-06 | — | — | US | claimed |
| EP-3624755-A1 | NAIL VARNISH COMPOSITION CONTAINING EMBOSSED EFFECT PIGMENTS AND SURFACE-MODIFIED EMBOSSED EFFECT PIGMENTS | ECKART GmbH (DE) | 2020-03-25 | — | — | EP | claimed |
| WO-2019022586-A9 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING LIVER CANCER | 주식회사 레모넥스 | 2019-07-25 | — | — | WO | claimed |
| WO-2019077021-A1 | NAIL VARNISH COMPOSITION CONTAINING EMBOSSED EFFECT PIGMENTS AND SURFACE-MODIFIED EMBOSSED EFFECT PIGMENTS | ECKART GMBH (DE) | 2019-04-25 | — | — | WO | claimed |
| US-7314850-B2 | Methods and compositions for treating subterranean formations with gelled hydrocarbon fluids | HALLIBURTON ENERGY SERVICES, INC. (US) | 2008-01-01 | — | — | US | claimed |
| EP-3659585-B1 | COMPOSITION FOR DELIVERING PHYSIOLOGICALLY ACTIVE INGREDIENTS INTO BLOOD VESSEL | LEMONEX INC (KR) | 2025-06-25 | — | — | EP | disclosed |
| CN-119789820-A | Endovascular occlusion device | 爱尔兰国立都柏林大学 | 2025-04-08 | — | — | CN | disclosed |
| CN-118903529-A | Composition for embolism | 上海玮沐医疗科技有限公司 | 2024-11-08 | — | — | CN | disclosed |
| US-12048757-B2 | Embossed effect pigment and method of manufacture of embossed effect pigment | ECKART GMBH (DE) | 2024-07-30 | — | — | US | disclosed |
| CN-115160600-B | Preparation method and application of mussel-like wet adhesion hydrogel based on hydrophobic chain drive | 西南交通大学 | 2024-06-14 | — | — | CN | disclosed |
| US-11760844-B2 | Dispersible antimicrobial complex and coatings therefrom | Poly Group LLC (US) | 2023-09-19 | — | — | US | disclosed |
| US-20230190597-A1 | Embossed Effect Pigment and Method of Manufacture of Embossed Effect Pigment | ECKART GMBH (DE) | 2023-06-22 | — | — | US | disclosed |
| US-6310036-B1 | High strength, Bio-compatible tissue adhesive and methods for treating vigorously bleeding surfaces | LAST CHANCE TISSUE ADHESIVES CORPORATION | 2001-10-30 | — | — | US | disclosed |
| EP-1140233-A1 | TISSUE ADHESIVE FOR TREATING VIGOROUSLY BLEEDING SURFACES | Browdie, David A. (US) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000040277-A1 | TISSUE ADHESIVE FOR TREATING VIGOROUSLY BLEEDING SURFACES | BROWDIE DAVID A (US) | 2000-07-13 | — | — | WO | disclosed |
| EP-0977619-A1 | COMPOSITIONS AND METHODS FOR INHIBITING FOULING OF VINYL MONOMERS | BetzDearborn Inc (US) | 2000-02-09 | — | — | EP | disclosed |
| US-5951748-A | AN ANTIFOULING AGENT COMPRISING ALKYLPHOSPHONATE ESTER OR ACID THEREOF FOR PREVENTING ACRYLATES, DIOLEFINS AND CHLORINATED HYDROCARBONS MONOMER DEPOSITING WHILE DISTILLATION | BETZDEARBORN INC. (US) | 1999-09-14 | — | — | US | disclosed |
| US-5858176-A | ADDING ALKYLPHOSPHONATE ESTER OR ACID AS ANTIFOULING AGENT | BETZDEARBORN INC. (US) | 1999-01-12 | — | — | US | disclosed |
| WO-1998047593-A1 | COMPOSITIONS AND METHODS FOR INHIBITING FOULING OF VINYL MONOMERS | BETZDEARBORN INC. (US) | 1998-10-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11760844-B2 | Dispersible antimicrobial complex and coatings therefrom | PICALM, WASF2, SAMM50 | LPAR3 2894/4885LPAR2 2621/4885FAAH 3628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.